Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 25, 1998

View Archived Issues

Lilly To Pay Xenova $35M For Heart Attack Drug

Gene Found That Keeps Female Embryos Female

Genset's Revenues Double; But R&D Spending Widens '97 Loss

Canadian Biotech Groups Merge To Form National Body

Appligène Oncor Reports Disappointing '97 Results

Foiled By Nonviral Vectors, Therexsys Shifts Gene Therapy

Cerep's IPO On Nouveau Marché Raises FFr67.5M

Germany Backs China's Biotech International Exhibition

EU Advisory Panel On Ethics Formed With Lenoir As Chairman

Amrad Acquires Diagnostic Firm For A$50M In Cash, Stock

HIV Drug Developer Frustrated; Pursuing Studies In China

Peptech Making Changes; Returning To Australia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....